Aileron therapeutics inc (ALRN)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16
Revenue

0

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Operating expenses:
Research and development

4,069

4,709

4,475

4,305

4,174

3,961

4,321

5,320

4,846

4,311

3,825

3,161

2,942

3,092

2,605

2,086

2,493

General and administrative

2,807

2,639

3,440

3,075

3,139

3,021

3,177

4,339

2,917

2,730

2,601

1,791

1,647

1,356

1,627

3,464

1,446

Total operating expenses

6,876

7,348

7,915

7,380

7,313

6,982

7,498

9,659

7,763

7,041

6,426

4,952

4,589

4,448

4,232

5,550

3,939

Loss from operations

-6,876

-7,348

-7,915

-7,380

-7,313

-6,982

-7,498

-9,659

-7,763

-7,041

-6,426

-4,952

-4,589

-4,448

-4,232

-5,550

-3,939

Gain on sale of property and equipment

66

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest income

62

112

166

208

100

-52

64

168

175

176

167

29

32

6

10

16

14

Net loss

-6,748

-7,236

-7,749

-7,172

-7,213

-7,034

-7,434

-9,491

-7,588

-6,865

-6,259

-4,923

-4,557

-4,442

-4,222

-5,534

-3,925

Accretion of redeemable convertible preferred stock to redemption value

-

-

-

-

-

-

-

-

-

0

0

21

20

19

19

19

18

Net loss

-

-

-

-

-

-

-

-

-

-6,865

-6,259

-4,944

-4,577

-4,461

-4,241

-5,553

-3,943

Net loss per share — basic and diluted

-0.24

-0.26

-0.28

-0.26

-0.49

-0.48

-0.50

-0.64

-0.52

-0.47

-0.45

-10.98

-10.58

-10.31

-9.84

-12.95

-9.25

Weighted average common shares outstanding—basic and diluted

27,810

27,810

27,810

27,526

14,816

14,745

14,737

14,737

14,732

14,720

13,939

450

432

432

430

428

426

Comprehensive loss:
Net loss

-6,748

-7,236

-7,749

-7,172

-7,213

-7,034

-7,434

-9,491

-7,588

-6,865

-6,259

-4,923

-4,557

-4,442

-4,222

-5,534

-3,925

Other comprehensive gain (loss):
Unrealized gain (loss) on investments, net of tax of $0

-8

-10

-7

24

5

-2

9

38

-17

-27

-6

-

-

1

-3

-5

7

Total other comprehensive gain (loss)

-8

-10

-7

24

5

-2

9

38

-17

-27

-6

-

-

1

-3

-5

7

Total comprehensive loss

-6,756

-7,246

-7,756

-7,148

-7,208

-7,036

-7,425

-9,453

-7,605

-6,892

-6,265

-4,923

-4,557

-4,441

-4,225

-5,539

-3,918